HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Panton-Valentine leukocidin expressing Staphylococcus aureus pneumonia managed with extracorporeal membrane oxygenation: experience and outcome.

AbstractOBJECTIVE:
Panton-Valentine leukocidin expressing Staphylococcus aureus pneumonia, an infection that affects predominantly young people, has a mortality rate of > 70% despite aggressive conventional management. Little information is available on the management of patients with Panton-Valentine leukocidin expressing S. aureus pneumonia with extracorporeal membrane oxygenation support. As a large extracorporeal membrane oxygenation center, we reviewed our experience and outcomes with Panton-Valentine Leukocidin expressing S. aureus pneumonia.
DATA SOURCES:
Locally held register of all extracorporeal membrane oxygenation patients at Glenfield Hospital.
STUDY SELECTION:
Retrospective study including all patients with sputum-positive Panton-Valentine leukocidin expressing S. aureus pneumonia managed with extracorporeal membrane oxygenation support at a single extracorporeal membrane oxygenation center.
DATA SYNTHESIS:
On review of our database held from September 1989 until date, there were four patients with sputum-confirmed Panton-Valentine leukocidin expressing S. aureus pneumonia managed with extracorporeal membrane oxygenation. Refractory hypoxemia and/or uncompensated hypercapnia despite optimal conventional management were the indications for extracorporeal membrane oxygenation. After varying periods on extracorporeal membrane oxygenation with appropriate antibiotic and ancillary care, all four patients were discharged home.
CONCLUSIONS:
Panton-Valentine leukocidin expressing S. aureus pneumonia can cause severe, necrotizing pneumonia associated with acute respiratory distress syndrome, which can be particularly challenging to manage. Extracorporeal membrane oxygenation support permits low pressure lung ventilation, avoiding barotrauma to lungs made friable by Panton-Valentine leukocidin expressing S. aureus infection. Although this is a small number of patients, the results are encouraging.
AuthorsMoronke A Noah, Michael Dawrant, Gail M Faulkner, Anne-Marie Hill, Chris Harvey, Abid Hussain, David R Jenkins, Sanjiv Nichani, Giles J Peek, Andrew W Sosnowski, Richard K Firmin
JournalCritical care medicine (Crit Care Med) Vol. 38 Issue 11 Pg. 2250-3 (Nov 2010) ISSN: 1530-0293 [Electronic] United States
PMID20711071 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bacterial Toxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin
Topics
  • Adolescent
  • Adult
  • Bacterial Toxins (biosynthesis)
  • Exotoxins (biosynthesis)
  • Extracorporeal Membrane Oxygenation
  • Female
  • Humans
  • Leukocidins (biosynthesis)
  • Male
  • Pneumonia, Staphylococcal (microbiology, therapy)
  • Pregnancy
  • Pregnancy Complications, Infectious (microbiology, therapy)
  • Staphylococcus aureus (metabolism)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: